Page last updated: 2024-11-13
cytoskyrin a
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
cytoskyrin A: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 44566948 |
CHEMBL ID | 449103 |
MeSH ID | M0377971 |
Synonyms (2)
Synonym |
---|
CHEMBL449103 |
cytoskyrin a |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (10)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID334567 | Antibacterial activity against Escherichia coli ATCC 25922 at 10 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334575 | Antifungal activity against Candida albicans at 10 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334568 | Antibacterial activity against Escherichia coli HBI 101 at 5 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334574 | Antifungal activity against Candida albicans at 5 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334566 | Antibacterial activity against Bacillus subtilis 168 at 10 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334564 | Antibacterial activity against Bacillus subtilis 168 at 5 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334563 | Antibacterial activity against Staphylococcus aureus ATCC 25923 at 10 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334562 | Antibacterial activity against Staphylococcus aureus ATCC 25923 at 5 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334565 | Antibacterial activity against Escherichia coli ATCC 25922 at 5 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
AID334569 | Antibacterial activity against Escherichia coli HBI 101 at 10 ug/disk by agar plate diffusion assay | 2002 | Journal of natural products, May, Volume: 65, Issue:5 | New metabolites from sponge-derived fungi Curvularia lunata and Cladosporium herbarum. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.75
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.75) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |